European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 447-448 , May 2010

Para-aortic lymph node dissection revisited: Have we been neglecting a promising treatment option for gastric carcinoma?

  • Y. Kodera

      Affiliations

    • Corresponding Author InformationTel.: +81 52 744 2250; fax: +81 52 744 2255.

,Accepted 25 March 2010.

References 

  1. Kodera Y, Schwarz R, Nakao A. Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials?. J Am Coll Surg. 2002;195(6):855–864
  2. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–462
  3. Roviello F, Pedrazzani C, Marrelli D, Di Leo A, Caruso S, Giacopuzzi S, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36(5):439–446
  4. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–1820
  5. Yoshikawa T, Sasako M, Sano T, Nashimoto A, Kurita A, Tsujinaka T, et al. Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial. Br J Cancer. 2006;93(12):1526–1529
  6. Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A, Polish Gastric Cancer Study Group , et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg. 2007;193(1):10–15

PII: S0748-7983(10)00068-5

doi: 10.1016/j.ejso.2010.03.012

European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 447-448 , May 2010

Article Tools